Insider · CIK 0001794698

Tardio Jason

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001794698

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-29	IMUXIMMUNIC, INC. · Stock OptionA Award	President and COO	AAward	+253K sh	—	—	253,000
2025-07-16	IMUXIMMUNIC, INC. · Stock Appreciation RightA Award	President and COO	AAward	+330K sh	—	—	330,000
2025-07-16	IMUXIMMUNIC, INC. · Stock Appreciation RightA Award	President and COO	AAward	+660K sh	—	—	660,000
2025-07-16	IMUXIMMUNIC, INC. · Stock Appreciation RightA Award	President and COO	AAward	+660K sh	—	—	660,000
2025-07-16	IMUXIMMUNIC, INC. · Stock Appreciation RightA Award	President and COO	AAward	+330K sh	—	—	330,000
2025-07-16	IMUXIMMUNIC, INC. · Stock Appreciation RightA Award	President and COO	AAward	+330K sh	—	—	330,000
2025-06-05	IMUXIMMUNIC, INC.P Purchase	President and COO	PPurchase	+12.5K sh	$0.79	+$9,884.48	12,512
2025-06-05	IMUXIMMUNIC, INC. · Stock OptionA Award	President and COO	AAward	+599K sh	—	—	598,500
2025-06-05	IMUXIMMUNIC, INC.P Purchase	President and COO	PPurchase	+12.5K sh	$0.79	+$9,884.48	12,512
2025-06-05	IMUXIMMUNIC, INC. · Stock OptionA Award	President and COO	AAward	+595K sh	—	—	595,000
2024-12-04	IMUXIMMUNIC, INC. · Stock OptionA Award	President and COO	AAward	+158K sh	—	—	157,500
2024-07-12	IMUXIMMUNIC, INC. · Stock OptionA Award	President and COO	AAward	+500K sh	—	—	500,000
2024-02-22	OVIDOvid Therapeutics Inc.A Award	Chief Operating Officer	AAward	+28.1K sh	—	—	28,125
2024-02-22	OVIDOvid Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+169K sh	—	—	168,750
2023-02-23	OVIDOvid Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+175K sh	—	—	175,000
2022-09-12	OVIDOvid Therapeutics Inc.S Sale	Chief Operating Officer	SSale	−17.3K sh	$2.15	−$37.3K	0
2022-04-08	OVIDOvid Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+87.5K sh	—	—	87,498
2022-04-08	OVIDOvid Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+10K sh	—	—	10,000
2022-02-03	OVIDOvid Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+175K sh	—	—	175,000
2021-07-01	OVIDOvid Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+50K sh	—	—	50,000
2021-02-05	OVIDOvid Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+75K sh	—	—	75,000
2020-12-17	OVIDOvid Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+175K sh	—	—	175,000
2020-11-25	OVIDOvid Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+44K sh	—	—	44,000
2020-06-19	OVIDOvid Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+50K sh	—	—	50,000
2019-11-18	OVIDOvid Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+125K sh	—	—	125,000

Recent filings

Accepted (ET)
Jun 294
Tardio Jason0001193805-26-000886
SEC(opens sec.gov)
Jul 184
Tardio Jason0001193805-25-001065
SEC(opens sec.gov)
Jun 204/A
Tardio Jason0001193805-25-000925
SEC(opens sec.gov)
Jun 94
Tardio Jason0001193805-25-000839
SEC(opens sec.gov)
Dec 64
Tardio Jason0001193805-24-001442
SEC(opens sec.gov)
Jul 124
Tardio Jason0001193805-24-000914
SEC(opens sec.gov)
Feb 264
Tardio Jason0001209191-24-003972
SEC(opens sec.gov)
Feb 274
Tardio Jason0001209191-23-013309
SEC(opens sec.gov)
Sep 144
Tardio Jason0001209191-22-049938
SEC(opens sec.gov)
Apr 124
Tardio Jason0001209191-22-024191
SEC(opens sec.gov)
Feb 44
Tardio Jason0001209191-22-007314
SEC(opens sec.gov)
Jul 14
Tardio Jason0001209191-21-044391
SEC(opens sec.gov)

Companies

Address

1200 AVENUE OF THE AMERICAS, SUITE 200

NEW YORK, NY, 10036